Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA 2025-08-01 22:00
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market 2025-08-01 20:00
Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease 2025-08-01 15:52
GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader 2025-08-01 10:02
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer 2025-07-31 18:36
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development 2025-07-31 17:55
Akeso Announces Completion of First Dosing in Phase III Clinical Trial of Ivonescimab (PD-1/VEGF) Combination Therapy for Immunotherapy-Resistant NSCLC 2025-07-31 09:46
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure 2025-07-31 04:10
BON Launches AI-Powered New Drug Research and Development 2025-07-30 21:00
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company 2025-07-30 20:00
Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025 2025-07-30 08:01
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort 2025-07-29 21:12
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress 2025-07-29 20:00
ArisGlobal Achieves Strong Global Growth and Continued Innovation in First Half 2025 2025-07-29 19:21
WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication 2025-07-29 16:00
Tigermed Completes Acquisition of Japanese CRO Micron 2025-07-29 13:37
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ 2025-07-29 10:37
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury 2025-07-28 21:10
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market 2025-07-28 20:28
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC) 2025-07-28 20:12
1 27 28 29 30 31 525